Federal health officials would study fibroids and share treatment information

The health secretary would support and coordinate research on uterine fibroids. The work would involve the National Institutes of Health and other relevant federal agencies. The $30 million yearly amount would authorize future funding; Congress would still need to approve the actual money. The research funding authorization would cover fiscal years 2026 through 2030.

The health secretary would establish or expand a database and report treatment spending to Congress. The database and spending report would cover fibroid treatment under Medicaid and the Children’s Health Insurance Program, including services under approved exceptions to standard program rules. The database would measure how often covered patients receive fibroid treatment. The spending report would be due within two years after the bill becomes law.

The health secretary would share public information and work with medical groups and health systems to promote care supported by research. Information would address patients and providers, including the higher fibroid risk among racial and ethnic minority groups. Treatment information would cover medically appropriate options, including treatments that do not remove the uterus. Work with providers would follow relevant medical societies’ guidelines. The bill would authorize funding without setting a dollar amount; Congress would still need to approve actual spending. Funding authorizations for these efforts would cover fiscal years 2026 through 2030.